Lantern Pharma Inc. Common Stock (LTRN) is a publicly traded Healthcare sector company. As of May 21, 2026, LTRN trades at $3.20 with a market cap of $38.28M and a P/E ratio of -2.01. LTRN moved +2.91% today. Year to date, LTRN is -2.46%; over the trailing twelve months it is -8.91%. Its 52-week range spans $1.11 to $6.12. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces LTRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Lantern Pharma Inc. Common Stock (LTRN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LTRN moved +2.91% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $3.20 |
| Market Cap | $38.28M |
| P/E Ratio | -2.01 |
| EPS | $-1.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.12 |
| 52-Week Low | $1.11 |
| Volume | 346.43K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-17.12M |
| Gross Margin | 0.00% |
1 analysts cover LTRN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.